This Week in Managed CareGuidelines Caution Opioid Use and Other Health News
Every week, The American Journal of Managed Care\xae\xa0recaps the top managed care news of the week.\n\nThis week in managed care, the top news includes survival improves among wait-listed heart transplant candidates, the Trump administration offers a progress report on its kidney care initiative, and panelists say choice is vital to the biosimilar savings picture.\n\nRead more about the stories in this podcast:\nSurvival Improves Among Wait-listed Heart Transplant Candidates: https://www.ajmc.com/view/survival-improves-among-wait-listed-heart-transplant-candidates\nAdministration Offers Progress Report on Kidney Care Initiative: https://www.ajmc.com/view/administration-offers-progress-report-on-kidney-care-initiative\nChoice Is Vital to Biosimilar Savings Picture, Panelists Say: https://www.ajmc.com/view/choice-is-vital-to-biosimilar-savings-picture-panelists-say\nDo ICD-10 Codes Accurately Reflect COVID-19 Symptoms? https://www.ajmc.com/view/do-icd-10-codes-accurately-reflect-covid-19-symptoms\nFor Short Bouts of Acute Pain, Avoid Opioids, Guidelines Caution: https://www.ajmc.com/view/for-short-bouts-of-acute-pain-avoid-opioids-guidelines-caution\nPopulation Targeting and Durability of Multimorbidity Collaborative Care Management: https://www.ajmc.com/view/population-targeting-and-durability-of-multimorbidity-colloborative-care-management